Vident Investment Advisory’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,668
| Closed | -$200K | – | 925 |
|
|
2023
Q2 | $200K | Buy |
+6,668
| New | +$200K | 0.01% | 1063 |
|
|
2022
Q3 | – | Sell |
-12,919
| Closed | -$374K | – | 1308 |
|
|
2022
Q2 | $374K | Sell |
12,919
-1,118
| -8% | -$32.4K | 0.01% | 940 |
|
|
2022
Q1 | $453K | Sell |
14,037
-840
| -6% | -$27.1K | 0.01% | 953 |
|
|
2021
Q4 | $434K | Buy |
14,877
+5,373
| +57% | +$157K | 0.01% | 967 |
|
|
2021
Q3 | $253K | Sell |
9,504
-5,779
| -38% | -$154K | 0.01% | 1036 |
|
|
2021
Q2 | $471K | Buy |
15,283
+5,351
| +54% | +$165K | 0.01% | 858 |
|
|
2021
Q1 | $260K | Sell |
9,932
-621
| -6% | -$16.3K | 0.01% | 930 |
|
|
2020
Q4 | $266K | Sell |
10,553
-295
| -3% | -$7.44K | 0.01% | 835 |
|
|
2020
Q3 | $226K | Buy |
+10,848
| New | +$226K | 0.01% | 815 |
|
|
2015
Q4 | – | Sell |
-52,952
| Closed | -$743K | – | 787 |
|
|
2015
Q3 | $743K | Buy |
+52,952
| New | +$743K | 0.1% | 304 |
|